IP Library › Assignment 055508/0666
Patent Assignment
Reel/Frame 055508/0666

Assignment of Assignor's Interest

Recorded: 2021-03-04 Pages: 6
Assignor
SYNTHON PHARMACEUTICALS, INC.
Executed: 2021-03-03
Assignee
EDGEMONT PHARMACEUTICALS, LLC.
1250 CAPITAL OF TEXAS HWY SOUTH, BUILDING 3, SUITE 400, AUSTIN, TEXAS, 78746
Covered Properties (2)
Venlafaxine Besylate
Patent: 6,717,015 →
Application: 10/397,373 →
Publication: US 2003/0195249
Extended Release Venlafaxine Besylate Tablets
Patent: 7,776,358 →
Application: 10/895,984 →
Publication: US 2006/0018963
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 27, 2003
From: KELTJENS, ROLF; PLATTEEUW, JOHANNES JAN; CUCALA ESCOI, JUAN; PICHA, FRANTISEK
To: SYNTHON BV
Reel/Frame 013915/0615 →
Assignment of Assignor's Interest Nov 15, 2004
From: CUCALA ESCOI, JOAN; GALLEGO LUENGO, MONTSERRAT; MARGALLO LANA, INOCENCIA
To: SYNTHON BV
Reel/Frame 015360/0628 →
Assignment of Assignor's Interest May 18, 2005
From: SYNTHON BV
To: SYNTHON IP INC.
Reel/Frame 016026/0687 →
Assignment of Assignor's Interest Apr 20, 2006
From: SYNTHON BV
To: SYNTHON IP INC.
Reel/Frame 017500/0617 →
Conversion to New State of Incorporation Jan 26, 2021
From: SYNTHON IP, INC.
To: SYNTHON IP OF NORTH CAROLINA, INC.
Reel/Frame 055122/0227 →
Change of Name Jan 28, 2021
From: SYNTHON IP OF NORTH CAROLINA, INC.
To: SYNTHON PHARMACEUTICALS, INC.
Reel/Frame 055155/0441 →
Assignment of Assignor's Interest Jun 29, 2021
From: EDGEMONT PHARMACEUTICALS, LLC
To: EDGEMONT PHARMACEUTICALS, LLC LIQUIDATING TRUST
Reel/Frame 057044/0880 →